NCT03760081 · Interventional trial
A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors
Overall registry status Completed
Phase 2
Conditions Incurable Platinum Refractory Germ Cell Tumors, Tumors
Delaware Valley sites
- Abramson Cancer Center University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory